Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2025 Poal.co

175

"The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate. "

"The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate. "
You are currently inside a comment thread.
Click here to see all the comments (2).
[–] • 4 pts 2mo

How to create a "safe and effective" vaccine.

Find a disease which used to be prevalent and deadly prior to advances in sanitation and nutrition. Create a "vaccine". Have it added to the "immunization register" so that you are immune from liability. Capture the "vigilance" system to design adverse event reporting and recording to be <5% effective. ... Profit.